WHO official hails ‘good news’ from early trials

News

In this handout photo released by the University of Oxford blood samples from coronavirus vaccine trials are handled inside the Jenner Institute in Oxford, England Thursday June 25, 2020. Scientists at Oxford University say their experimental coronavirus vaccine has been shown in an early trial to prompt a protective immune response in hundreds of people who got the shot. In research published Monday July 20, 2020 in the journal Lancet, scientists said that they found their experimental COVID-19 vaccine produced a dual immune response in people aged 18 to 55. (John Cairns, University of Oxford via AP)

GENEVA — The head of emergencies at the World Health Organization is hailing “good news” in results shown by two COVID-19 vaccine candidates in early trials, but warns “there’s a long way to go.”

“We now need to move into larger-scale real-world trials,” Dr. Michael Ryan told reporters at a news conference in Geneva. “But it is good to see more data and more products moving into this very important phase of vaccine discovery.”

Ryan’s comments came as scientists at Oxford University, in a paper published in The Lancet, said their experimental vaccine had been shown to trigger a protective immune response in hundreds of people who got the shot.

Also in the medical journal, Chinese researchers published a study on their experimental vaccine, using a similar technique as the Oxford team, that reported an immune response.

Ryan noted there are 23 COVID-19 candidate vaccines in clinical development, but until Monday only one had produced Phase 1 clinical data.

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

High School Standouts
Ask the Expert
Shred-A-Thon
Basketball Challenge Bracket Contest
Find A Job
wspa news app free for download choose your store below
download the wspa news app from the apple app store
download the wspa news app from the google play store